RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 146 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,712,435 | +120.1% | 406,662 | +154.4% | 0.02% | +142.9% |
| Q4 2022 | $1,232,312 | +3.8% | 159,833 | +43.3% | 0.01% | 0.0% |
| Q3 2022 | $1,187,000 | +521.5% | 111,575 | +376.7% | 0.01% | +600.0% |
| Q2 2022 | $191,000 | -69.9% | 23,408 | -73.6% | 0.00% | -80.0% |
| Q1 2022 | $635,000 | +9.7% | 88,748 | +162.7% | 0.01% | -16.7% |
| Q4 2021 | $579,000 | -9.1% | 33,777 | +22.0% | 0.01% | -25.0% |
| Q3 2021 | $637,000 | +28.4% | 27,686 | +103.6% | 0.01% | +33.3% |
| Q2 2021 | $496,000 | – | 13,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |